LeadIQ logo
Learn more at LeadIQ.com

Insights

AI Drug Discovery Leader Genesis Therapeutics is a leading AI-driven biotechnology research company, utilizing its innovative GEMS platform to discover novel small molecule therapies. This cutting-edge technology presents a strong sales opportunity for pharmaceutical companies seeking advanced drug discovery solutions.

High-Value Partnerships Genesis Therapeutics has established strategic collaborations with industry giants like Eli Lilly and Genentech, as well as recent partnerships with Gilead Sciences and NVIDIA. Leveraging these partnerships, sales professionals can explore synergistic opportunities with these key players and potentially expand business networks.

Significant Funding and Financial Health With over $280 million in funding and a revenue range of $10-50 million, Genesis Therapeutics exhibits financial stability and growth potential. This financial health signals a strong buying capacity, making them an attractive prospect for partners looking for sustainable business collaborations.

Rapid Team Expansion Genesis Therapeutics is rapidly growing its team, with various openings in machine learning, computational chemistry, and software roles. This growth signifies increased operational capacity and expertise, offering a sales opportunity for service providers catering to expanding biotech companies.

Market Trend Setter Established in 2019 and making significant strides in AI-driven drug discovery, Genesis Therapeutics is positioned as a trendsetter in the market. Sales professionals can tap into this trendsetting image to align with innovative solutions and cater to the evolving needs of the biotechnology research sector.

Similar companies to Genesis Therapeutics

Genesis Therapeutics Tech Stack

Genesis Therapeutics uses 8 technology products and services including Cloudflare CDN, Google Workspace, Google Cloud, and more. Explore Genesis Therapeutics's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Google Workspace
    Email
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • HTTP/3
    Miscellaneous
  • Google
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Python
    Programming Languages

Media & News

Genesis Therapeutics's Email Address Formats

Genesis Therapeutics uses at least 1 format(s):
Genesis Therapeutics Email FormatsExamplePercentage
First@genesistherapeutics.aiJohn@genesistherapeutics.ai
76%
FLast@genesistherapeutics.aiJDoe@genesistherapeutics.ai
20%
FL@genesistherapeutics.aiJD@genesistherapeutics.ai
3%
Middle@genesistherapeutics.aiMichael@genesistherapeutics.ai
1%

Frequently Asked Questions

Where is Genesis Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Genesis Therapeutics's main headquarters is located at Chapin Ave Burlingame, California 94010 US. The company has employees across 2 continents, including North AmericaSouth America.

What is Genesis Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Genesis Therapeutics's official website is genesistherapeutics.ai and has social profiles on LinkedIn.

How much revenue does Genesis Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, Genesis Therapeutics's annual revenue reached $15M.

What is Genesis Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Genesis Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Genesis Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, Genesis Therapeutics has approximately 100 employees across 2 continents, including North AmericaSouth America. Key team members include Chief Scientific Officer: S. P.Head Of People, Sr. Director: I. H. W.Head Of Immunology & Inflammation: G. A.. Explore Genesis Therapeutics's employee directory with LeadIQ.

What industry does Genesis Therapeutics belong to?

Minus sign iconPlus sign icon
Genesis Therapeutics operates in the Biotechnology Research industry.

What technology does Genesis Therapeutics use?

Minus sign iconPlus sign icon
Genesis Therapeutics's tech stack includes Cloudflare CDNGoogle WorkspaceGoogle CloudjQueryHTTP/3GoogleOpen GraphPython.

What is Genesis Therapeutics's email format?

Minus sign iconPlus sign icon
Genesis Therapeutics's email format typically follows the pattern of . Find more Genesis Therapeutics email formats with LeadIQ.

How much funding has Genesis Therapeutics raised to date?

Minus sign iconPlus sign icon
As of August 2024, Genesis Therapeutics has raised $200M in funding. The last funding round occurred on Aug 21, 2023 for $200M.
Genesis Therapeutics

Genesis Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Genesis Therapeutics – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego – is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery.

The GEMS platform integrates deep learning-based predictive models, molecular simulations, and molecular generative AI. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through multiple cycles of AI-enabled discovery and optimization. 

We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022) and Genentech (signed in 2020).

Genesis has raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. We are rapidly growing our team with a variety of openings on our machine learning, computational chemistry, and software teams (primarily located in the Bay Area) and our chemistry, biology, and clinical teams (primarily located in San Diego). To learn more about Genesis Therapeutics, or current employment opportunities, please visit our website.

Section iconCompany Overview

Headquarters
Chapin Ave Burlingame, California 94010 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $200M

    Genesis Therapeutics has raised a total of $200M of funding over 5 rounds. Their latest funding round was raised on Aug 21, 2023 in the amount of $200M.

  • $10M$50M

    Genesis Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $200M

    Genesis Therapeutics has raised a total of $200M of funding over 5 rounds. Their latest funding round was raised on Aug 21, 2023 in the amount of $200M.

  • $10M$50M

    Genesis Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.